Supriya Life - Pullback Trade
Good numbers by the company and expansion to 2x capacity complete. Just awaiting US FDA approval now.
The company has a good growth trajectory going ahead...modestly valued at 30 PE when you compare it to other pharma names most of which are trading at over 50PE..
There could be some rerating here too..
If it pulls back to 570 I think its a buy with Stoploss below 520.
The company has a good growth trajectory going ahead...modestly valued at 30 PE when you compare it to other pharma names most of which are trading at over 50PE..
There could be some rerating here too..
If it pulls back to 570 I think its a buy with Stoploss below 520.
Aviso legal
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.